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Rational design of allosteric ribozymes 
Jin Tang and Ronald R Breaker 
Background: Efficient operation of cellular processes relies on the strict 
control that each cell exerts over its metabolic pathways. Some protein enzymes 
are subject to allosteric regulation, in which binding sites located apart from the 
enzyme’s active site can specifically recognize effector molecules and alter the 
catalytic rate of the enzyme via conformational changes. Although RNA also 
performs chemical reactions, no ribozymes are known to operate as true 
allosteric enzymes in biological systems, It has recently been established that 
small-molecule receptors can readily be made of RNA, as demonstrated by the 
in vitro selection of various RNA aptamers that can specifically bind 
corresponding ligand molecules. We set out to examine whether the catalytic 
activity of an existing ribozyme could be brought under the control of an effector 
molecule by designing conjoined aptamer-ribozyme complexes, 
Results: By joining an ATP-binding RNA to a self-cleaving ribozyme, we have 
created the first example of an allosteric ribozyme that has a catalytic rate that 
can be controlled by ATP. A 180-fold reduction in rate is observed upon 
addition of either adenosine or ATP, but no inhibition is detected in the 
presence of dATP or other nucleoside triphosphates. Mutations in the aptamer 
domain that are expected to eliminate ATP binding or that increase the distance 
between aptamer and ribozyme domains result in a loss of ATP-specific 
allosteric control. Using a similar design approach,,allosteric hammerhead 
ribozymes that are activated in the presence of ATP were created and another 
ribozyme that can be controlled by theophylline was created. 
Address: Department of Molecular, Cellular and 
Developmental Biology, Yale University, New 
Haven, Connecticut 06520-8103, USA. 
Correspondence: Ronald R Breaker 
E-mail: ronald.breaker@yale.edu 
Key words: aptamer, ATP, RNA engineering, RNA 
enzyme, self-cleaving RNA 
Received: 16 April 1997 
Revisions requested: 9 May 1997 
Revisions received: 16 May 1997 
Accepted: 20 May 1997 
Chemistry & Biology June 1997, 4:453-459 
http://biomednet.com/elecref/1074552100400453 
0 Current Biology Ltd ISSN 1074-5521 
Conclusions: The catalytic features of these conjoined aptamer-ribozyme 
constructs demonstrate that catalytic RNAs can also be subject to allosteric 
regulation -a key feature of certain protein enzymes. Moreover, by using simple 
rational design strategies, it is now possible to engineer new catalytic 
polynucleotides which have rates that can be tightly and specifically controlled 
by small effector molecules. 
Introduction 
The regulation of metabolic processes involves a variety of 
molecular mechanisms including transcriptional and trans- 
lational control, RNA and protein degradation, and cat- 
alytic induction and inhibition. A number of enzymatic 
processes are subject to allosteric regulation, in which the 
catalytic activity of a key enzyme in a metabolic pathway is 
induced or inhibited upon binding of an allosteric effector 
molecule. Allosteric regulation of protein enzymes involves 
allosteric binding sites, located apart from the active site of 
the enzyme, that can specifically recognize effector mol- 
ecules. Binding of the effector molecule to the allosteric 
binding site induces conformational changes in the protein 
structure that alter the catalytic rate of the enzyme. 
Natural ribozymes [l-4] and ribozymes that have been 
isolated by in vitro selection [S-7], are not known to 
operate as true allosteric enzymes. The activity of natural 
catalytic RNAs, however, can be greatly affected by spe- 
cific proteins that support proper structural folding [8-131. 
It then seems likely that small-molecule effecters could 
perform similar functions. Indeed, small antibiotic mol- 
ecules have been shown both to inhibit and enhance the 
catalytic rates of certain ribozymes [14-161, although these 
molecules typically bind directly to the catalytic domain of 
the RNA and these phenomena are not defined as 
allostery. Given the significant structural and functional 
potential for catalytic RNAs [S-7], there would also appear 
to be significant potential for nucleic acids to function as 
allosteric enzymes. For example, RNA and DNA aptamers 
have the capacity to form distinct secondary and tertiary 
structures that can function as receptors, binding a variety 
of small organic ligands with considerable affinity and 
specificity [17-191. These aptamers can be manipulated as 
modular receptor elements, a characteristic that has been 
exploited for the in vitro selection of novel ribozymes that 
make use of pre-existing ligand-binding domains [20,21]. 
Certain characteristics of ribozyme function can be ‘engi- 
neered’ in a rational fashion by judicious use of simple 
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Figure 1 Table 1 
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Hammerhead ribozyme constructs. (a) Hl (shown bracketed) is 
‘HH15’, originally characterized by Fedor and Uhlenbeck [40]. Roman 
numerals identify stems that form the hammerhead secondary 
structure. Stem II is also indicated in red. Construct H2 carries an 
additional G-C base pair in stem I and is flanked on each end by 
accessory sequences that are designed as short hairpins to reduce the 
occurrence of inactive structures. (b) Construct H3 is an integrated 
hammerhead ribozyme that includes an ATP-specific and adenosine- 
specific aptamer (shown in blue and red) [24]. Constructs H4 and H5 
are modified versions of H3 that include an aptamer-domain mutation 
and a three base-pair extension of stem II, respectively. Arrowheads 
indicate the site of ribozyme-mediated cleavage. 
design strategies that make use of Watson-Crick base- 
pairing rules, thermodynamic stability of RNA duplexes, 
conformational changes, and the modular use of RNA 
functional domains [5,6,22]. Here, using these simple 
rational design concepts, we joined aptamer domains with 
hammerhead self-cleaving ribozymes [23], to create a 
series of catalytic RNAs that are amenable either to nega- 
tive or to positive allosteric control by small-molecule 
effecters. For our initial work, we used the 40-nucleotide 
ATP-binding aptamer (ATP40-1) that was described by 
Sassanfar and Szostak [24]. The ATP40-l aptamer shows 
specific affinity for adenosine 5’ triphosphate (ATP; 
K,-IOpM) and adenosine, but has no detected affinity for 
a variety of ATP analogs including 2’-deoxyadenosine 5’ 
triphosphate (dATP) or the remaining three natural 
Catalytic rates of various ribozyme constructs. 
kobs (min-1) 
Construct Stem II None ATP dATP 
HI 
H2 
H3* 
H4+ 
H5* 
H6* 
H7* 
0.58 - 
0.10 - 
CAAC 
III1 0.054 0.0003 
GUUG 
CAAC 
I I I I 0.042 0.061 
GUUG 
CAAGGCC 
lllllll 0.075 0.13 
GUUCCGG 
CGUAUGC 
I**I**I 0.022 0.12 
GUGUGUG 
CGUGUGC 
I . . . . . I 0.0012 0.0098 
GUGUGUG 
0.053 
0.027 
0.0009 
*Constructs containing a functional ATP aptamer. +Constructs 
containing a defective ATP aptamer. Constructs H6 and H7 are 
identical to H5 except for the indicated changes in stem II. -, Kinetic 
values not determined. 
ribonucleoside triphosphates. This aptamer also under- 
goes a significant conformational change upon ligand 
binding, as determined by chemical probing studies. We 
reasoned that these characteristics might be exploited to 
create a conjoined aptamer-ribozyme molecule that could 
be subject to ATP-dependent allosteric control. 
Results and discussion 
We used the bimolecular hammerhead ribozyme construct 
Hl as a basis for the design of new constructs (Figure 1). 
First, we appended sequences at the 5’ and 3’ termini to 
make the new constructs amenable to amplification by 
reverse transcription-polymerase chain reaction methods 
for use in subsequent studies, giving construct HZ 
(Figure la) [25]. Construct H2 also differs from Hl in that 
it has an additional G-C base pair in stem I. These changes 
cause a sixfold reduction in kobs for H2 compared to that of 
Hl (Table 1). We next modified stem II to carry the ATP 
aptamer, giving construct H3 (Figure lb). Our decision to 
locate the aptamer here was made primarily because 
changes in stem II can have large effects on the catalytic 
rates of hammerhead ribozymes [26,27]. In the absence of 
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Figure 2 
ATP-mediated and adenosine-mediated 
inhibition of a hammerhead ribozyme. 
(a) Hammerhead constructs Hl, H2 and H3 
(400 nM) were incubated with trace amounts 
of [5’-szP]-labeled substrate (S) in the 
absence (-) or presence (+) of 1 mM ATP for 
30 min. (b) The specificity of the effector 
molecule was examined by incubating H3 and 
S for 45 min as described above in the 
absence (-) or presence of 1 mM of various 
nucleotides as indicated. Similarly, constructs 
H4 and H5 were examined for activity in the 
presence of 1 mM ATP. Reaction products 
were separated by PAGE (200/o, denaturing) 
and visualized by autoradiography. E, S and P 
identify enzyme, substrate and product bands, 
respectively. 
(a) Hl H2 H3 
S 
+ - + + 
W H3 H4 H5 
S 
ATP, this alteration in H3 causes an additional twofold 
reduction in rate compared to that observed with Hl. 
The RNA-cleavage activity of H3 is significantly reduced 
when incubated with 1 mM ATP (Figure Za). In contrast, 
ATP has no effect on the cleavage activity of Hl or HZ. 
Moreover, inhibition is observed in the presence of adeno- 
sine, but not with dATP or the other ribonucleoside 
triphosphates (Figure Zb). This inhibition is highly spe- 
cific and is consistent with the previously determined 
binding specificity of the aptamer [24]. 
To further investigate the mechanism of inhibition of 
H3 by ATP, we designed two additional integrated 
aptamer-ribozyme constructs (Figure 1). Construct H4 is 
identical to H3, but carries a G + C mutation that disrupts 
the consensus sequence of the ATP aptamer. This same 
guanine residue was strictly conserved among the selected 
ATP-binding RNAs, and a G-+A mutation at this posi- 
tion has already been shown to eliminate ATP binding by 
the ATP-40-1 aptamer domain [24]. As expected, this 
mutation eliminates the allosteric inhibition effect of ATP 
with H4 (Figure Zb). 
We speculated that the allosteric effect observed with H3 
might be due to the close proximity of the aptamer and 
hammerhead domains. Specifically, structural models of the 
hammerhead indicate a parallel orientation for stems I and 
II [Z&30]. In the uncomplexed state, the aptamer domain 
is likely to exist in a single or a set of conformational state(s) 
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Figure 3 
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Kinetic analysis of the catalytic inhibition of H3 by ATP. (a) Plot of the 
fraction of substrate cleaved with H3 (400 nM) in the presence of 
1 OuM (open circles) and 1 mM (filled circles) ATP. Dashed line 
represents the average initial slope obtained in the absence of ATP or 
in the presence of as much as 1 mM dATP. (b) Plot of H3 ribozyme 
activity (k,& in the presence of various concentrations of dATP (open 
circles) and ATP (filled circles). Also plotted on the y axis are kobs 
values for Hl (open squares), H2 (filled squares) and H3 (open 
circles) with no added effector molecules. 
that allow catalysis to proceed unhindered. When com- 
plexed with ATP, this domain undergoes a conformational 
change that presumably causes steric interference between 
structures that are appended to stems I and II. To test this 
hypothesis, we designed construct H5 (Figure 1) which has 
an additional three base pairs in helix II, further separating 
the aptamer and ribozyme domains. Expansion of stem II 
from four (H3) to seven (H5) base pairs completely elimi- 
nates ATP-dependent inhibition of ribozyme function 
(Figure Zb). Computer modeling using the recently pub- 
lished structures of the ATP aptamer [31] and the hammer- 
head ribozyme [ZB] are consistent with an allosteric 
inhibition mechanism that involves RNA conformational 
change and the mutually exclusive formation of aptamer 
and ribozyme domains (data not shown). We are now pro- 
ceeding with additional experiments to examine the 
detailed mechanism of ATP-dependent inhibition of H3 
and related aptamer-ribozyme constructs. 
The inhibitory effect of ATP with H3 has been confirmed 
and quantitated by kinetic analyses. This conjoined 
aptamer-ribozyme construct displays different cleavage 
rates, after a brief burst phase, with different concentra- 
tions of ATP (Figure 3a). The catalytic burst, usually of 
3-S% substrate cleavage, was often observed when the 
effector molecule and the Mg2+ cofactor were added simul- 
taneously. This effect was minimized or even eliminated, 
however, by a S-10 min preincubation of the RNA con- 
struct with the effector molecule prior to initiating the 
reaction with Mg2+. The catalytic burst seen in the absence 
of preincubation with effector is probably due to a minor 
fraction of the ribozyme population that has yet to reach 
the structurally inactive state prior to reaction initiation. 
Further evidence that ribozyme catalysis is modulated by 
ATP binding is obtained by examining the ATP-depen- 
dent catalytic rate of H3. A plot of kobs against ATP or 
dATP concentration (Figure 3b) demonstrates that H3 
undergoes -180-fold reduction in catalytic rate with 
increasing concentrations of ATP, but is not inhibited by 
dATP. The ribozyme activity curve generated by varying 
the ATP concentration indicates that 50% ribozyme inhibi- 
tion occurs with an ATP concentration near lOpM, which 
closely predicts the K, of the aptamer for its ligand. 
We investigated whether ATP could also be made to func- 
tion as a positive effector of ribozyme function by design- 
ing construct H6 and subsequently construct H7 
(Figure 4a), both of which were found to display ATP- 
dependent allosteric induction. The construct H6 is similar 
to H5, except that four Watson-Crick base pairs in stem II 
are replaced with less stable G*U mismatches [32]. These 
changes are expected to weaken stem II significantly and 
result in diminished ribozyme activity. Here we intended 
to exploit the fact that the G-C pair that begins stem II 
within the aptamer domain is not paired in the absence of 
ATP, but will form a stable pair when ATP is complexed 
[24], thereby increasing the overall stability of the stem 
and inducing catalytic activity. Indeed, we find an approxi- 
mately fivefold reduction in catalytic activity with H6 com- 
pared to H5 when assayed in the absence of ATP, yet we 
can specifically and fully recover H6 catalytic function by 
the addition of ATP (Table 1). The catalytic rate of H6 is 
also enhanced by ATP when it is added during the course 
of the reaction (Figure 4b). Similarly, ATP induces the 
catalytic rate of H7 by nearly tenfold (Table 1). 
Allosteric induction by ATP with H6 and H7 is significantly 
less than the corresponding ATP-induced rate reduction 
seen with H3. It is possible that other effects may con- 
tribute part or all of the catalytic rate enhancement seen 
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Figure 4 
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ATP-dependent allosteric induction of integrated ribozyme constructs. 
(a) Integrated constructs for allosteric induction by ATP (H6 and H7) 
and allosteric inhibition by theophylline (H8). Stem II is shown in red. 
H7 differs from H6 in that the central U-A pair is replaced with a GU 
mismatch and it is designed to further reduce hammerhead catalysis in 
the absence of ATP. H8 is analogous to H3 except that the ATP- 
aptamer domain is replaced by the theophylline aptamer (shown in 
blue and red) corresponding to ‘mTCT8-4’ that was described by 
Jenison et a/. [38]. Arrowheads indicate the site of ribozyme-mediated 
cleavage. (b) Induction of ribozyme catalysis during the course of a 
ribozyme reaction was examined by incubating H6 in the absence 
(open circles) and presence (open squares) of 1 mM ATP, and when 
ATP is added (filled circles) to a final concentration of 1 mM during an 
ongoing ribozyme reaction. Arrow indicates the time of ATP addition. 
upon the addition of ATP to H6 and H7. As noted above, 
the addition of the ATP-binding domain results in a twofold 
drop in ribozyme activity when assayed in the absence of 
ATP. Perhaps the formation of a defined ATP-binding 
structure upon the addition of ATP prevents the disordered 
aptamer domain from incidentally interfering with the func- 
tion of the ribozyme domain. Further experimentation is 
necessary to determine the contribution of each structural 
change towards the sum of allosteric induction. 
As with allosteric effecters of proteins, there is no true simi- 
larity between the effector molecule and the substrate of 
the ribozyme. Substrate and effector occupy different 
binding sites, yet conformational changes upon effector 
binding result in functional changes in the neighboring cat- 
alytic domain. In a previous study, Peracchi eta/. [33] found 
that nucleosides could restore the catalytic activity of 
certain analogs of hammerhead ribozyme that carry abasic 
sites within their catalytic core. The allosteric ribozymes 
described in this report are distinct from these examples, in 
that the binding site for the allosteric effector in our designs 
lies apart from the catalytic core of the ribozyme, and that 
the catalytic rates of different ribozyme constructs can 
either be inhibited or enhanced by effector molecules. The 
characteristics of the conjoined aptamer-ribozyme com- 
plexes parallel the characteristics that are typically ascribed 
to natural allosteric enzymes that are made of protein. Our 
proposed model for the mechanism of ATP-dependent 
control of ribozymes H3, H6 and H7 involves the specific 
recognition of ATP at a separate binding site that is distinct 
from the active site, thereby inducing a conformational 
change that results in the alteration of catalytic rate of the 
adjacent ribozyme. Specifically, we have preliminary bio- 
chemical data that are consistent with the formation of a 
steric interaction between stem I of the hammerhead and 
the extraneous stem-loop of the ATP-binding aptamer 
domain (J.T. and R.R.B., unpublished observations). The 
putative mechanism, which is identical to that indicated by 
computer-aided structural modeling, relies entirely on ter- 
tiary structure alterations. If correct, this mechanism corre- 
sponds well with the original definition for allosteric control 
of protein enzymes that was originally put forth by Monod 
and coworkers [34,3.5]. 
Using similar model studies, we can now begin to build a 
palette of design options and strategic approaches that can 
be used to create ribozymes with controlled catalytic activ- 
ity. The principles used here (secondary binding sites, 
conformational changes, steric effects and structural stabi- 
lization) as well as others may be generally applicable and 
can be used to’design additional allosteric ribozymes, or 
even allosteric ‘deoxyribozymes’ [36,37]. For example, we 
have designed an allosteric hammerhead that includes the 
theophylline aptamer described by Jenison eta]. [38]. This 
construct (H8, Figure 4a) displays an approximately five- 
fold reduction in ribozyme activity (kobs of 7.4~ 1O-3 min-l 
compared to 1.6~10-~min-l) when theophylline is added 
to a final concentration of lOOl.tM (data not shown). We 
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are now planning to investigate whether the magnitude of 
allosteric inhibition or enhancement can be expanded. For 
example, further revisions of the prototypic allosteric 
ribozymes described in this report could be made to refine 
the interplay between the aptamer and ribozyme motifs to 
improve the net inhibition or enhancement of ribozyme 
catalytic rates. These improvements can be achieved by 
making adjustments to the current constructs via rational 
design, or by constructing a combinatorial library of RNAs 
followed by screening via in vitro selection [7]. 
The specificity of allosteric control of ribozymes can be 
exquisite, and in our example the ribozyme activity is 
sensitive to the difference of a single oxygen atom in the 
effector molecule. This sophisticated mode of enzyme 
regulation may have been critical in the ‘RNA world’ 
[39], where ribozymes would have had to take advantage 
of a variety of catalytic and regulatory mechanisms to 
maintain a complex metabolic state. We have already 
exploited an H3-like allosteric design to create unimolec- 
ular aptamer-ribozyme constructs that can be prepared by 
in vitro transcription without undergoing self-destruction 
[25]. As with H3, these unimolecular self-cleaving ver- 
sions of allosteric ribozymes are inhibited during tran- 
scription by ATP, which is present as a substrate for RNA 
polymerase. It is now practical to contemplate the design 
of a variet? of new allosteric ribozymes that are analogous 
to certain protein enzymes in their ability to be regulated 
by small-molecule effecters. Allosteric ribozymes could 
be exploited as rate-regulated catalysts or as ‘molecular 
switches’ that could be used to activate or deactivate 
various biological and chemical processes. Novel biosen- 
sors and controllable therapeutic ribozymes, for example, 
might be of significant importance. 
Significance 
Using a rational design approach, we have created a 
series of conjoined aptamer-ribozyme complexes that 
are subject to allosteric regulation by adenosine and 
ATP. The conjoined structures can be designed to give 
either allosteric induction or allosteric inhibition, with 
catalytic rates in the presence and absence of effector 
molecule that differ by over two orders of magnitude. 
These results demonstrate that catalytic RNA mol- 
ecules can be subject to tight regulatory control, a 
kinetic feature that increases the potential for RNA to 
direct sophisticated metabolic processes. 
This study has focused primarily on the use of a single 
ATP-specific aptamer domain and on the use of a single 
self-cleaving ribozyme. This entire process can most 
likely be generalized and expanded to create new 
allosteric ribozymes that have different catalytic func- 
tions and that respond to different effector molecules. 
Growth in the understanding of nucleic acid structure 
and function will increase the rate at which ribozyme 
engineers can design new catalysts using rational means, 
although combinatorial methods can also be used. Con- 
sidering the propensity of both RNA and DNA to fold 
into complex shapes, and in view of the increasing 
number of RNA and DNA aptamers that are being 
made by in vitro selection, it seems reasonable to specu- 
late that a variety of allosteric ribozymes and deoxyri- 
bozymes could be engineered for practical applications. 
Materials and methods 
Ribozyme preparation 
Each ribozyme and conjoined aptamer-ribozyme was prepared by 
in vitro transcription from double-stranded DNA templates that were 
produced by the polymerase chain reaction using the corresponding 
antisense DNA template and the primers 5’GAATTCTAATACG. 
ACTCACTATAGGCGAAAGCCGGGCGA and 5’GAGCTCTCGCTA. 
CCGT. Transcription reactions (50 ~1) containing 30 pmoles template 
DNA were incubated in 50mM Tris-HCI (pH 7.5 at 23%), 15mM 
MgCI,, 5 mM dithiothreitol, 2 mM spermidine, 2 mM of each NTP, 20 PCi 
[cF~‘PI-UTP and 600 units T7 RNA polymerase for 2 h at 37°C. RNA 
products were separated by polyacrylamide gel electrophoresis 
(PAGE), visualized by autoradiography and the ribozymes were recov- 
ered from excised gel by crush-soaking in 10 mM Tris-HCI (pH 7.5 at 
23”C), 200mM NaCl and 1 mM EDTA and quantified by liquid scintilla- 
tion counting. The RNA substrate was prepared (Keck Biotechnology 
Resource Laboratory, Yale University, USA) by standard solid-phase 
methods and the 2’-TBDMS group was removed by 24 h treatment with 
triethylamine trihydrofluoride (15 ~1 per AU260 crude RNA). Substrate 
RNA was purified by PAGE, isolated by crush-soaking, [5’-32PI-labeled 
with T4 polynucleotide kinase and [Y-~~PI-ATP, and repurified by PAGE. 
Ribozyme catalysis assays 
Ribozyme activity assays were conducted under single turnover condi- 
tions with ribozyme in excess over trace amounts of substrate. Replicate 
k ohs values obtained for Hl and H2 at 200, 400 and 800 nM ribozyme 
concentration under identical assay conditions differed by less that 
twofold, suggesting that for each construct, kobs values approach the 
maximum value. Reactions also contained 50 mM Tris-HCI (pH 7.5 at 
23°C) and 20 mM MgCI,, and were incubated at 23°C with concentra- 
tions of effector molecules and incubation times as noted for each 
experiment. Ribozyme and substrate were preincubated separately for 
-1Omin in reaction buffer and also with effector molecules when 
present, and reactions were initiated by combining preincubated mix- 
tures. We find that, even after exhaustive incubation with Hi, approxi- 
mately 45% of the substrate RNA remains uncleaved. It is not 
uncommon for a subset of RNA molecules prepared by chemical means 
to carry chemical modifications that render the RNA resistant to cleav- 
age, and this probably explains the fact that some substrate remains 
uncleaved. The kinetic caI&lations have been adjusted accordingly. 
Ribozyme kinetics 
Catalytic rates (kabs) were obtained by plotting the fraction of substrate 
cleaved against time and establishing the slope of the curve that repre- 
sents the initial velocity of the reaction by a least-squares fit to the data. 
Kinetic assays were analyzed by PAGE and were visualized and ana- 
lyzed on a Molecular Dynamics Phosphorimager. When minor-burst 
kinetics were encountered, a post-burst slope was used in the calcula- 
tions. Replicate experiments routinely gave kobs values that differed by 
less than 50% and the values reported are averages of two or more 
experiments. Equivalent rates were also obtained for duplicate ribozyme 
and substrate preparations. 
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